Fortum's divestment of Infratek ASA completed Espoo,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Fortum's divestment of Infratek ASA completed

Espoo, Finland, 2013-07-26 08:30 CEST (GLOBE NEWSWIRE) -- PRESS RELEASE 26 July 2013

Fortum has today completed the divestment of its 33% holding in Infratek ASA to a fund managed by Triton, following the approval of the Swedish and Norwegian competition authorities.

The sales price is approximately EUR 37 million. Fortum will book a sales gain of approximately EUR 10 million in the Power Division's third-quarter 2013 results.

The divestment is in line with Fortum's aim to strengthen its strategic focus by divesting non-core assets, such as minority holdings, and is part of the company's efficiency programme launched in October 2012.

Fortum Corporation Corporate Communications

Further information: Timo Karttinen, Executive Vice President, Electricity Solutions and Distribution Division, Fortum, tel. +358 50 453 6555 Fortum Fortum's purpose is to create energy that improves life for present and future generations. We provide sustainable solutions that fulfil the needs for low emissions, resource efficiency and energy security, and deliver excellent value to our shareholders. Our activities cover the generation, distribution and sales of electricity and heat as well as related expert services. Fortum's operations focus on the Nordic countries, Russia, Poland and the Baltics. In the future, the integrating European and fast-growing Asian energy markets provide additional growth opportunities. In 2012, Fortum’s sales totalled EUR 6.2 billion and comparable operating profit was EUR 1.7 billion. We employ approximately 10,400 people. Fortum’s shares are quoted on NASDAQ OMX Helsinki. Further information: www.fortum.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ovation's Roadmap for Revitalizing Rural Healthcare

Updated Category News Views 5

Steering Rural Healthcare Towards a Brighter Future Alright, here we are with Ovation Healthcare trying to inject some much-needed life into the sometimes forgotten corners of the healthcare world—those rural hospitals. They’ve cooked up a fresh white paper, and it’s got the makings of a lifeline for these institutions swirling in red ink. The financial landscape...

Continue Reading
ProperHeir Expands with New Innovative Office Space

Updated Category News Views 194

ProperHeir Expands with New Innovative Office Space ProperHeir has recently announced an exciting development with the opening of its new office at the Miramar Tech Center. This expansion marks a significant milestone as the company has tripled its available space. The chief purpose of this new office is to effectively host its growing in-house sales team and provide a...

Continue Reading
Discover How Octa Transforms Forex Trading for Singaporeans

Updated Category News Views 95

Understanding the Forex Market The foreign exchange market, commonly known as forex, stands as the largest and most dynamic financial market in the world. It allows traders to buy and sell currencies, leveraging the fluctuations in exchange rates to boost their earnings. Operating continuously from Monday to Friday, this market presents individual traders with the chance...

Continue Reading
Seoul Business Agency Powers Startups at the CES 2026 Pavilion

Updated Category News Views 176

Seoul Business Agency Showcases Startups at CES 2026 Pavilion The Seoul Business Agency (SBA) has taken ambitious strides to support the innovative spirit of Seoul's startups at CES 2026. Engaging with 19 prestigious institutions within Seoul’s ecosystem, the SBA is dedicated to empowering 70 startups as they venture onto the global stage. The 'Seoul POP' themed...

Continue Reading
VYJUVEK® Receives Groundbreaking Approval for DEB Treatment

Updated Category News Views 252

VYJUVEK® Approved for Dystrophic Epidermolysis Bullosa Treatment VYJUVEK approved for DEB treatment from birth, offering flexible home administration options for patients and their families. This breakthrough marks VYJUVEK as the first genetic medicine approved in Japan for DEB. Recently, Krystal Biotech, Inc. (NASDAQ: KRYS) announced that its innovative treatment,...

Continue Reading